Correlation Between Molecular Partners and Regulus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Regulus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Regulus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Regulus Therapeutics, you can compare the effects of market volatilities on Molecular Partners and Regulus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Regulus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Regulus Therapeutics.
Diversification Opportunities for Molecular Partners and Regulus Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Regulus is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Regulus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regulus Therapeutics and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Regulus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regulus Therapeutics has no effect on the direction of Molecular Partners i.e., Molecular Partners and Regulus Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Partners and Regulus Therapeutics
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.86 times more return on investment than Regulus Therapeutics. However, Molecular Partners is 1.86 times more volatile than Regulus Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Regulus Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 418.00 in Molecular Partners AG on September 3, 2024 and sell it today you would earn a total of 122.00 from holding Molecular Partners AG or generate 29.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Regulus Therapeutics
Performance |
| Timeline |
| Molecular Partners |
| Regulus Therapeutics |
Molecular Partners and Regulus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Regulus Therapeutics
The main advantage of trading using opposite Molecular Partners and Regulus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Regulus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regulus Therapeutics will offset losses from the drop in Regulus Therapeutics' long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Regulus Therapeutics vs. Tenax Therapeutics | Regulus Therapeutics vs. Verastem | Regulus Therapeutics vs. Pulmatrix | Regulus Therapeutics vs. Cellectar Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |